Dr. Jacob's GranaProstan 100 Capsules

Dr. Jacob's GranaProstan Food Supplement 100 Capsules is a capsule product containing pomegranate juice and pulp in powder form and elderberry polyphenols.

The product is obtained through fermentation with probiotic bacteria. This treatment makes the ingredients more accessible to the body. Furthermore, Dr. Jacob's GranaProstan contains less sugar than fresh Punica granatum fruit juice. This means it can also be taken by people who struggle with high blood sugar levels.

The capsules are made without zoonotic products, so this supplement can also be used by vegans.

Research suggests that pomegranate juice may have properties that reduce lipid peroxidation and act as an antioxidant. Interestingly, it also increases the production of nitric oxide, which naturally dilates blood vessels [1].

Polyphenols are organic compounds of plant origin that belong to the phenol group and contain at least two hydroxyl groups bound to the aromatic ring. Many of them exhibit strong antioxidant properties.

Black elderberry is also an antioxidant, but also contributes to maintaining normal blood sugar levels. It also strengthens the immune system and has a healing effect on the upper respiratory tract. It also supports blood circulation and influences the condition of blood vessels.

Interestingly, Sambucus nigra L. also plays a role in less obvious processes. As a dietary component, it facilitates weight loss and allows for healthy weight maintenance. Furthermore, it contributes to increased water excretion from the body.

In summary, the dietary supplement Dr. Jacob's GranaProstan ferment 100 capsules is a product of natural plant origin that has antioxidant and immune-boosting properties.

[Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Phase II study of pomegranate juice for men with rising prostate-specific antigen after surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 1;12(13):4018-26. doi: 10.1158/1078-0432.CCR-05-2290. PMID: 16818701.